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n higher vertebrates that are active during the
day (eg,humans,chicks,and dogs,but not rats,which are
nocturnal),nighttime melatonin secretion is temporally
associated with sleep.Analysis of 24-h urine samples from
young and elderly people alike (Figure 1),with or without
insomnia,clearly shows a direct correlation between sleep
and urinary excretion of 6-sulfatoxymelatonin.
1 Subjects
with insomnia have a considerably reduced production of
melatonin from their pineal gland, which is due to a
decrease in the level of the enzyme serotonin N-acetyl-
transferase (NAT).Insomnia could therefore be due to a
lack of this NAT enzyme in the pineal gland.
These observations have led several groups to propose
treating sleep disorders by administration of melatonin
or melatoninergic compounds,in order to compensate for
the lack of melatonin observed in subjects with insomnia.
Pineal melatonin secretion in humans
We have demonstrated that melatonin is a bioprecursor of
hypnotic acetyl metabolites produced by enzymatic acetyl-
ation of melatonin and 2-oxomelatonin under the control
of acetyltransferases,most probably the NAT enzymes.
In 1994, in our laboratory, we developed a specific and
highly sensitive gas chromatography–mass spectrometry
(GC-MS) method
2 to assay,simultaneously and distinctly,
plasma concentrations of endogenous melatonin (D0-
melatonin) and exogenous melatonin (D7-melatonin),in
which 7 atoms of H have been substituted by 7 atoms of
deuterium.Using the same human volunteers (12 young
subjects in June 1994 and 12 elderly subjects in October
1994),we determined the pharmacokinetics of exogenous
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Pharmacokinetic studies of melatonin in young and
elderly human volunteers, and the measurement of hyp-
notic effects in chicks under alternate light–dark or per-
manent light conditions, show that melatonin is a bio-
precursor of hypnotic acetyl metabolites produced by the
enzymatic acetylation of both melatonin and 2-oxomela-
tonin under the control of serotonin N-acetyltransferases
(NATs), which are present in the pineal gland. The acetyl
metabolite of melatonin, which we call carbo2, is an N-
acetyl- -carboline. The electroencephalographic (EEG)
architecture of the sleep produced by this compound is
similar to that of physiological sleep, and is characterized
by the significant proportion of slow-wave deep sleep and
rapid eye movement sleep. This is in sharp contrast to the
EEG sleep architecture observed with GABAergic (GABA,
 -aminobutyric acid) compounds. Since insomnia and
sleep disorders are believed to be due to a lack of NAT
enzymes in the pineal gland, a new therapeutic approach
of sleep disorders by administration of such hypnotic
acetyl metabolites of melatonin, or synthetic analogs
thereof, can be envisaged. Dialogues Clin Neurosci. 2002;4:395-401.
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ID7-melatonin,when given orally and intravenously,and
the kinetics of the pineal secretion of endogenous D0-
melatonin.
3,4
The results shown in Figure 2 led to the following con-
clusions:
• Secretion of melatonin by the pineal gland occurs only
during the night.
• Pharmacokinetic analysis shows that the rate of mela-
tonin secretion by the pineal gland is constant through-
out the whole nocturnal pineal melatonin production,
for the same subject.
•The clock times at the beginning and end of melatonin
secretion from the pineal gland are the same for each
subject,whatever the season and night length.Duration
of melatonin pineal secretion is between 7.5 and 8 h.
Therefore,melatonin secretion and sleep are contem-
poraneous.
•There is a large interindividual variability in the
amount of melatonin released in plasma by the pineal
gland during the night in young and old subjects alike.
Hypnotic effect of melatonin and NAT 
in the CNS
Results of previous related studies show that melatonin
secretion,and therefore the presence of melatonin in the
central nervous system (CNS),is necessary for the induc-
tion and maintenance of nocturnal sleep.However,the
presence of melatonin in the CNS is insufficient for the
induction and maintenance of sleep.Indeed,Figure 3 and
Table I show results of observations in chicks in an alter-
nate light (L)–dark (D) program (L/D, 12 h:12 h), in
which the light phase lasted from 8.00 AM until 8.00 PM.
When melatonin was administered intramuscularly (pec-
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Figure 1. Mean 6-sulfatoxymelatonin concentrations over 36 h in young
people without sleep disorders (dark blue squares), elderly peo-
ple without sleep disorders (light blue squares), independently
living elderly patients with insomnia (dark blue circles), elderly
patients with insomnia living in nursing home (light blue cir-
cles).
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Figure 2. Nighttime plasma concentrations of melatonin in 12 young sub-
jects (A: June 1994) and 12 elderly subjects (B: October 1994).
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Atoralis major muscle) during the light phase from 2.00 PM
to 8.00 PM,the chicks did not exhibit any signs of a hyp-
notic effect.The absence of a hypnotic effect during the
light phase correlated with the very low level of NAT
activity in the pineal glands of chicks measured at the
same times.
In contrast,when chicks were observed in a 7-day per-
manent light program (L/L, 12 h:12 h), during which
NAT activity level was constantly higher,
5 the adminis-
tration of melatonin induced a significant hypnotic effect.
The duration of sleep (between 4 and 5 h) was much
greater than that observed with diazepam (between 1
and 2 h) when it was administered intramuscularly at the
same dose (1 µM per 100 g body weight,at 2.00 PM).
These results lead to the following conclusions:
•The simultaneous presence of melatonin and NAT in
the CNS (pineal gland) is a necessary and sufficient
condition for the induction and maintenance of sleep.
• In contrast to the classic so-called “hypnotic drugs”(eg,
benzodiazepines, barbiturates, zopiclone, and zolpi-
dem),melatonin does not have direct hypnotic prop-
erties related to its chemical structure. Its hypnotic
effects depend on the activity of NAT in the CNS.
Melatonin: a bioprecursor of hypnotic 
metabolites
During the development of the GC-MS method for the
assay of melatonin in plasma,
2 our attention was focussed
on the chemical reactivity of melatonin at position 3,
which allows cyclization of the side chain after acylation.
This proceeds by nucleophilic attack and leads to a fluo-
roacyl-β-carboline (Figure 4).
Considering our previous observations,we assumed that
melatonin undergoes enzymatic acetylation during the
night,under the control of NAT,and that this leads to an
N-acetyl-β-carboline,which we call carbo2.We conclude
that melatonin is a bioprecursor of hypnotic acetyl
metabolites, such as carbo2. We have validated this
assumption in several ways.
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Table I. Intramuscular (pectoralis major muscle) administration of mela-
tonin, diazepam, and placebo in chicks under a 7-day alternate
light–dark program (LD) (light 8.00 AM to 8.00 PM; dark 8.00 PM
to 8.00 AM) or a permanent light program (LL). At 2 PM, the
chicks were administered doses equivalent to 1 µM for 100 g
body weight, dissolved in 0.2 mL of an ethanol–water mixture,
50/50, V/V.
LD (low) LL (high)
Placebo
• Doze time (min) 0 0
• Sleep time (min) 0 0
Melatonin
• Doze time (min) 0 4 to 5
• Sleep time (min) 0 240 to 300
Diazepam
• Doze time (min) 4 to 5 4 to 5
• Sleep time (min) 30 to 40 50 to 117
Figure 3. Change in N-acetyltransferase (NAT) activity in the pineal glands of chicks. A. Intramuscular (pectoralis major muscle) administration of trypt-
amine at 2 PM (arrow) in chicks in a 7-day alternate light–dark program (light 8.00 AM to 8.00 PM; dark 8.00 PM to 8.00 AM). The NAT activ-
ity increases from 8.00 PM and decreases from 4.00 AM. B. Intramuscular (pectoralis major muscle) administration of 5-methoxytryptamine at
2 PM (arrow) in chicks in a 7-day permanent light program.
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Figure 5. Acetylation capacity of various substrates in chick pineal glands
in an alternate light–dark program (light 6.00 AM to 6.00 PM;
dark 6.00 PM to 6.00 AM) and collected in the middle of dark
phase (midnight). NAS, N-acetylserotonin; 5-MT, 5-methoxy-
tryptamine; 5-HT, 5-hydroxytryptamine (serotonin); MEL, mela-
tonin. *P<0.002; **P<0.001; ***P<0.0005; ****P<0.00005.
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Figure 6. Acetylation capacity of various substrates in chick pineal
glands in an alternate light–dark program (light 8.00 AM to
8.00 PM; dark 8.00 PM to 8.00 AM) and collected 1 h before
the light phase (7.00 AM). 5-MT, 5-methoxytryptamine; 
MEL, melatonin; 2-oxo-MEL, 2-oxomelatonin. *P<0.0002;
**P<0.00005; ***P<0.0005.
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Figure 4. Perfluoroacylation of melatonin. Chemical structure of the fluoroacyl derivative obtained during the derivatization of melatonin using PFPA
(pentafluoropropionic anhydride), according the gas chromatography–mass spectrometry (GC-MS) analysis. Acetyl CoA, acetyl coenzyme A;
T, temperature.
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TAcetylation of melatonin in chick pineal glands
Chick pineal glands were observed during an alternate
light–dark program at 37°C for 7 days.In the middle of
dark phase,they were treated with [
3H]acetyl coenzyme
A and melatonin (or 2-oxomelatonin) for 30 min.
• Figures 5 and 6 show that melatonin (or 2-oxomela-
tonin) undergoes an acetylation that is significantly
higher (P<0.002,in the middle of dark phase;P<0.0005,
1 h before end of dark phase [or P<0.00005 for 2-
oxomelatonin over the whole dark phase]) than that
observed in controls (nonsignificant when melatonin
was replaced by phosphate buffer).
• GC-MS indicated the biosynthesis of [
3H]carbo2 for
five chick pineal glands collected in the middle of dark
phase (Table II).
Synthesis of carbo2
We have synthesized several acetyl derivatives,such as
carbo2 (Figure 7),which is an N-acetyl-β-carboline.We
have found 20 to 40 pg carbo2 per gram of lamb pineal
gland collected on the middle of the dark phase of an
alternate light–dark program.
Hypnotic activity of carbo2
The hypnotic activity of carbo2 has been observed and
measured in chicks and beagles:
• In chicks, the tests were performed at 2.00 PM, in the
middle of light phase,a time at which NAT activity in
the pineal gland is very low.The results are presented
in Table III,together with some reference compounds.
The essential role of acetyl group is demonstrated by
the fact that 10-methoxyharmalan (as well as harma-
line),which is the product of N-deacetylation of com-
pound carbo2,does not exhibit any hypnotic effect.In
contrast, it induces excitatory effects in chicks by
increasing locomotor activity.
• In beagles, polysomnographic studies showed that
when carbo2 was administered intravenously,it induced
sleep of longer duration and shorter time latencies than
the sleep induced by zolpidem and diazepam (Table
IV).
The most interesting feature,which provides more support
for our assumption,is the EEG architecture of the sleep
produced,which is similar to that of physiological sleep
(see results with placebo in Table IV),characterized by the
significant proportion of slow-wave deep sleep and rapid
eye movement (REM) sleep,in sharp contrast to the EEG
sleep architecture observed with GABAergic (GABA,γ-
aminobutyric acid) compounds, such as zolpidem or
diazepam,which induce mainly drowsiness (light sleep)
and little REM sleep.
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Table III. Hypnotic effects of carbo2, melatonin, and reference com-
pounds. Intramuscular (pectoralis major muscle) administration
at 2 PM to chicks under a 7-day alternate light–dark program (LD)
(light 8.00 AM to 8.00 PM; dark 8.00 PM to 8.00 AM). NA, not
applicable, the animals remained conscious throughout the
period of observation; FAT, time taken to fall asleep, equal to the
time required to pass from the state of active consciousness to a
nonconscious state; ST, sleep time, equal to the duration of the
period of sleep from falling asleep to waking up.
Compound Dose FAT ST
(µM/100 g  (min) (min)
body weight)
Placebo (20 batches) NA 0
Melatonin 0.5 (2 batches) NA 0
1 (5 batches) NA 0
2 (5 batches) NA 0
Pentobarbital 0.5 (3 batches) NA 0
1 (2 batches) 13 36
Diazepam 1 (10 batches) 2 to 7 24 to 70
Carbo2 1 (8 batches) 2 to 9 36 to 65
2 (10 batches) 4 to 11 40 to 70
10-Methoxyharmalan 1.4 (2 batches) NA 0
Harmaline 1.4 (2 batches) NA 0
Table II. Amount of [
3H]carbo2 collected from five chick pineal glands 
the middle of the dark phase of an alternate light–dark (12 h:
12 h) program.
Chick pineal gland [
3H]Carbo2 (pg/pineal gland)
15 0
25 0
33 0
45 0
55 0
Figure 7. Molecular structure of carbo2 (N-acetyl-β-carboline).
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We have evidenced the role played by melatonin in both
inducing and maintaining nocturnal sleep.Melatonin is
the bioprecursor of hypnotic acetyl metabolites,such as
carbo2,which result from the enzymatic acetylation of
melatonin (and 2-oxomelatonin) by NAT.
Since insomnia and sleep disorders may be due to a lack of
NAT enzymes in the pineal gland,a therapeutic approach
to sleep disorders could be suggested.Patients with insom-
nia may be treated by administering hypnotic acetyl
metabolites of melatonin or their synthetic analogs. ❏
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Table IV. Polysomnographic recordings of latencies and times spent at each stage of the sleep/wakefulness cycles after intravenous administration of
placebo, zolpidem, carbo2, and diazepam to 8 beagles for 90 to 150 min (mean values in 8 dogs). SWS, slow-wave sleep; REM, rapid eye
movement; S1, S2, S3, sleep states.
Dose Duration of Duration (min) Latencies (min)
(mg/kg) observation (% total sleep) (SD)
(min)
Wake Drowsiness SWS REM Total S1 SWS REM
S1 S2 + S3 sleep
Placebo 0 120 92.6 10.3 14.2 3.5 27.4 66.5 77.0 98.7
(37.6) (51.8) (12.7) (16.6) (9.3) (10.3)
Zolpidem 0.62 150 132.1 10.4 7.3 0.2 17.9 106.5 129.3 146.4
(58.1) (40.8) (1.1) (24.2) (22.5) (8.8)
Carbo2 1.28 90 32.2 23.6 30.2 4.0 57.8 15.9 27.8 58.1
(40.8) (52.2) (6.9) (14.8) (11.7) (14.9)
Carbo2 0.32 90 48.1 17.5 20.2 4.2 41.9 24.5 39.8 75.7
(41.8) (48.2) (10.0) (9.5) (18.6) (17.8)
Diazepam 0.20 90 58.5 20.1 10.3 1.1 31.5 24.0 45.5 80.3
(63.8) (32.7) (3.5) (5.0) (23.0) (15.6)
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Papel de la melatonina en la inducción y
mantención del sueño
Los estudios farmacocinéticos de la melatonina en
voluntarios humanos jóvenes y viejos, y la medición
de los efectos hipnóticos en pollos en condiciones
de alternancia luz-oscuridad o luz permanente,
muestran que la melatonina es un bioprecursor de
metabolitos acetilados hipnóticos, los que son pro-
ducidos por la acetilación enzimática de la melato-
nina y de la 2-oxomelatonina, ambas bajo control
de las N-acetiltransferasas (NATs) que se encuentran
en la glándula pineal. El metabolito acetilado de la
melatonina, que se denomina carbo2, es una N-ace-
til- -carbolina. La arquitectura electroencefalográ-
fica (EEG) del sueño producida por este compuesto
es similar al sueño fisiológico y se caracteriza por un
porcentaje significativo de sueño profundo de
ondas lentas y sueño de movimientos oculares rápi-
dos. Esto está en claro contraste con la arquitectura
del sueño EEG observado con compuestos gabaér-
gicos (GABA, ácido  -aminobutírico). Ya que se cree
que el insomnio y los trastornos del sueño se deben
a una falta de enzimas NAT en la glándula pineal,
se puede considerar una nueva aproximación tera-
péutica a los trastornos del sueño al administrar
metabolitos acetilados hipnóticos de melatonina o
análogos sintéticos de éstos.
Rôle de la mélatonine dans le 
déclenchement et le maintien du sommeil
Les études pharmacocinétiques sur la mélatonine
chez des volontaires humains jeunes et âgés, et la
mesure des effets hypnotiques chez des poussins
mis dans des conditions alternant lumière/obscurité
ou lumière permanente, montrent que la mélato-
nine est un bioprécurseur de métabolites hypno-
tiques acétylés produits par l’acétylation enzyma-
tique à la fois de la mélatonine et de la 2-oxo
mélatonine sous le contrôle des sérotonine N-acétyl-
transférases (NAT), qui sont présentes dans la
glande pinéale. Le métabolite acétylé de la méla-
tonine, désigné sous le terme de carbo2, est une N-
acétyl- -carboline. Contrastant nettement avec l’ar-
chitecture électroencéphalographique (EEG) du
sommeil observée avec les composés GABAergiques
(GABA, acide  -aminobutyrique), l’architecture EEG
du sommeil produite par le carbo2 est semblable
à celle du sommeil physiologique et est caractérisée
par la proportion significative de sommeil profond
à ondes lentes et de sommeil à mouvements ocu-
laires rapides. Puisque l’insomnie et les troubles du
sommeil semblent dus à un déficit pinéal en
enzymes N-acétyltransférases, il est possible d’envi-
sager une nouvelle approche thérapeutique des
troubles du sommeil par l’administration de méta-
bolites hypnotiques acétylés de la mélatonine ou
d’analogues de synthèse.